Monashee Investment Management LLC lessened its stake in Gossamer Bio, Inc. (NASDAQ:GOSS – Free Report) by 34.8% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,459,854 shares of the company’s stock after selling 1,844,358 shares during the period. Gossamer Bio […]
Wedbush Begins Coverage on Gossamer Bio (NASDAQ:GOSS) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Wedbush reaffirmed their outperform rating on shares of Gossamer Bio (NASDAQ:GOSS – Free Report) in a report released on Wednesday, Benzinga reports. The brokerage currently has a $6.00 price target on the stock. Wedbush also issued estimates for Gossamer Bio’s Q1 2024 earnings at ($0.17) EPS, Q2 2024 earnings at ($0.17) EPS, Q3 2024 earnings […]
Gossamer Bio (NASDAQ:GOSS) PT Lowered to $8 00 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Wedbush restated their outperform rating on shares of Gossamer Bio (NASDAQ:GOSS – Free Report) in a research note issued to investors on Wednesday morning, Benzinga reports. The firm currently has a $6.00 price target on the stock. Wedbush also issued estimates for Gossamer Bio’s Q1 2024 earnings at ($0.17) EPS, Q2 2024 earnings at ($0.17) […]